212 related articles for article (PubMed ID: 17567949)
1. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
2. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
3. Abnormal brain iron homeostasis in human and animal prion disorders.
Singh A; Isaac AO; Luo X; Mohan ML; Cohen ML; Chen F; Kong Q; Bartz J; Singh N
PLoS Pathog; 2009 Mar; 5(3):e1000336. PubMed ID: 19283067
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
5. Quaternary Structure Changes for PrP
Eskandari-Sedighi G; Cortez LM; Yang J; Daude N; Shmeit K; Sim V; Westaway D
Mol Neurobiol; 2021 Jan; 58(1):375-390. PubMed ID: 32959170
[TBL] [Abstract][Full Text] [Related]
6. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
7. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.
Singh A; Mohan ML; Isaac AO; Luo X; Petrak J; Vyoral D; Singh N
PLoS One; 2009; 4(2):e4468. PubMed ID: 19212444
[TBL] [Abstract][Full Text] [Related]
8. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation.
Hölscher C; Delius H; Bürkle A
J Virol; 1998 Feb; 72(2):1153-9. PubMed ID: 9445012
[TBL] [Abstract][Full Text] [Related]
10. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
11. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
12. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
[TBL] [Abstract][Full Text] [Related]
13. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
[TBL] [Abstract][Full Text] [Related]
14. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.
Määttänen P; Taschuk R; Ross L; Marciniuk K; Bertram L; Potter A; Cashman NR; Napper S
Prion; 2013; 7(5):434-9. PubMed ID: 24105298
[TBL] [Abstract][Full Text] [Related]
15. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.
Asthana A; Baksi S; Ashok A; Karmakar S; Mammadova N; Kokemuller R; Greenlee MH; Kong Q; Singh N
Sci Rep; 2017 Aug; 7(1):9600. PubMed ID: 28851903
[TBL] [Abstract][Full Text] [Related]
16. Insect cell-derived cofactors become fully functional after proteinase K and heat treatment for high-fidelity amplification of glycosylphosphatidylinositol-anchored recombinant scrapie and BSE prion proteins.
Imamura M; Kato N; Okada H; Yoshioka M; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
PLoS One; 2013; 8(12):e82538. PubMed ID: 24367521
[TBL] [Abstract][Full Text] [Related]
17. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
Vorberg I; Raines A; Priola SA
J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human prion protein inhibits prion propagation in vitro.
Yuan J; Zhan YA; Abskharon R; Xiao X; Martinez MC; Zhou X; Kneale G; Mikol J; Lehmann S; Surewicz WK; Castilla J; Steyaert J; Zhang S; Kong Q; Petersen RB; Wohlkonig A; Zou WQ
Sci Rep; 2013 Oct; 3():2911. PubMed ID: 24105336
[TBL] [Abstract][Full Text] [Related]
19. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
20. Protease-resistant prions selectively decrease Shadoo protein.
Watts JC; Stöhr J; Bhardwaj S; Wille H; Oehler A; Dearmond SJ; Giles K; Prusiner SB
PLoS Pathog; 2011 Nov; 7(11):e1002382. PubMed ID: 22163178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
